Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway

Arch Biochem Biophys. 2017 Nov 1:633:29-39. doi: 10.1016/j.abb.2017.09.002. Epub 2017 Sep 4.

Abstract

Objective: To determine the relationship between papillary thyroid carcinoma and environmental exposure to bisphenol A (BPA) or 17-β estrogen (E2) by assessing the effects of these compounds on estrogen receptor expression and AKT/mTOR signaling.

Methods: The effects of low levels of BPA (1mM-10nM) and 17β-estradiol (E2, 0.1mM-1nM) on ER expression and cellular proliferation were determined in human thyroid papillary cancer BHP10-3 cells. Protein and mRNA levels of estrogen nuclear receptors (ERα/ERβ) and membrane receptors (GPR30) were determined by immunofluorescence assay, Western blotting, and RT-PCR, respectively, and proliferation was assessed by CCK-8 assay.

Results: The proliferative effects of BPA and E2 were both concentration- and time-dependent. Expression of ERα/ERβ and GPR30 were enhanced by BPA and E2. BPA and E2 could quickly phosphorylate AKT/mTOR. Moreover, ICI suppressed ERα expression and activated GPR30 as did G-1. G-15 reversed the effects of E2 on GPR30 and AKT/mTOR, but did not alter the effect of BPA.

Conclusions: BPA influences thyroid cancer proliferation by regulating expression of ERs and GPR30, a mechanism that differs from E2. In addition, ICI and G-15 may have the potential to be used as anti-thyroid cancer agents.

Keywords: AKT; Bisphenol A; Estrogen receptor; Thyroid cancer; mTOR.

MeSH terms

  • Air Pollutants, Occupational / pharmacology*
  • Benzhydryl Compounds / pharmacology*
  • Benzodioxoles / pharmacology
  • Cell Cycle / drug effects
  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology*
  • Estrogen Receptor alpha / agonists
  • Estrogen Receptor alpha / genetics*
  • Estrogen Receptor alpha / metabolism
  • Estrogen Receptor beta / agonists
  • Estrogen Receptor beta / genetics*
  • Estrogen Receptor beta / metabolism
  • Fulvestrant
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Phenols / pharmacology*
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Quinolines / pharmacology
  • Receptors, Estrogen / antagonists & inhibitors
  • Receptors, Estrogen / genetics
  • Receptors, Estrogen / metabolism
  • Receptors, G-Protein-Coupled / antagonists & inhibitors
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism
  • Signal Transduction
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism
  • Thyroid Epithelial Cells / drug effects*
  • Thyroid Epithelial Cells / metabolism
  • Thyroid Epithelial Cells / pathology
  • Time Factors

Substances

  • 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline
  • Air Pollutants, Occupational
  • Benzhydryl Compounds
  • Benzodioxoles
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • GPER1 protein, human
  • Phenols
  • Quinolines
  • Receptors, Estrogen
  • Receptors, G-Protein-Coupled
  • Fulvestrant
  • Estradiol
  • MTOR protein, human
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • bisphenol A